Tweeter button Delicious button Digg button Stumbleupon button
Monthly Archives: April 2014
Fatty Liver Disease | Low Vitamin D Linked To Fatty Liver Disease In UK Children

The research, conducted by the King’s College Hospital Paediatric Liver Centre and the University of Surrey’s School of Biosciences and Medicine, and funded by the Children’s Liver Disease Foundation retrospectively analysed the medical records of 120 paediatric patients with NAFLD.The findings could carry significant implications for UK clinicians in light of the nation’s rising number of    .. more …

Facebook Twitter Email

Liver Cancer | Immunotherapy Could Help Tackle Tough Liver Cancer

PUBLIC RELEASE DATE: 11-Apr-2014 Contact: Courtney Lock Courtney.Lock@cohnwolfe.com 44-789-438-6422 European Association for the Study of the Liver Immunotherapy could help tackle tough liver cancer London, England, Friday 11 April 2014 Significant new data presented today at the International Liver Congress 2014 indicate that liver cancer (Hepatocellular Carcinoma (HCC)) may be treated by    .. more …

Facebook Twitter Email

Liver Diseases | Organisation To Promote Awareness Of Liver Diseases

It seeks to dispel myths misguiding people’s understanding of the risks and impact of liver diseases. A voluntary organisation, CLF has been conducting regular screening camps. Free treatment is provided to those who cannot afford it. CLF also strives to collect a corpus fund to use for the treatment of liver diseases, including surgery for cancers involving the liver and pancreas, according to a    .. more …

Facebook Twitter Email

Liver Disease | Liver Transplant Scheme Extended

People with a severe alcohol-related liver disease will be eligible for liver transplants for the first time in the UK under a pilot scheme.NHS Blood and Transplant (NHSBT) said only those under 40 who had not previously been treated for a drink problem would be eligible.Severe alcohol-associated hepatitis patients would account for 1% of all liver transplants each year.One in five liver    .. more …

Facebook Twitter Email

Liver Cancer Symptoms | 10 Discredited Or Untested Hiv ‘cures’ – Article Dashboard Directory

The Remarkable Recovery of Andrew Stimpson Anecdotally, there have been a lot of cases of people spontaneously recovering for no reason whatsoever, but in November 2005, two British newspapers broke the story of Andrew Stimpson. In May 2002, Stimpson underwent HIV testing and was diagnosed as positive. In August that year, he underwent two further tests – both of which confirmed the original    .. more …

Facebook Twitter Email

Liver Diseases | Lumena Pharmaceuticals Raises $45 Million In Series B Financing

SAN DIEGO, March 11, 2014 /PRNewswire/ –Lumena Pharmaceuticals (Lumena), a biopharmaceutical company focused on the development and commercialization of novel products for rare cholestatic liver diseases and serious metabolic disorders, today announced that it has secured $45 million in Series B financing. New Enterprise Associates (NEA) led the financing, with Adage Capital Management and RA    .. more …

Facebook Twitter Email

Fatty Liver Disease | First Cohort Results In Galectin Therapeutics' Phase 1 Trial Reveal Biomarker Evidence Of Therapeutic Effect On …

The Phase 1 multi-center, blinded (to healthcare providers and patients) clinical trial is being conducted in patients with NASH with advanced fibrosis (Brunt Stage 3) who receive four doses of GR-MD-02 over a 42-day period. Each of the three planned cohorts consists of eight patients, six randomized to receive active drug and two randomized to receive placebo. Eight U.S. clinical sites with    .. more …

Facebook Twitter Email

Important Disclaimer: Article Comments provided are for general information purposes only and are not intended to substitute for informed professional medical, psychological, tax, accounting, legal, investment, or any other professional advice. We expressly disclaim liability for any product, manufacturer, distributor, service or service provider mentioned or any opinion expressed in these comments or anywhere else within the site. Lastly, we do not endorse any article or comment. Use at your own risk.